Primary effectiveness was measured by the number of patients with HIV-1 RNA ≥50 copies/mL at Week 48, as well as the number of patients with a change in CD4 cell count, and the proportion of patients ...

Gilead Sciences has developed an industry-leading HIV portfolio in recent years with its megablockbuster daily treatment ...

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

Meet the SanDisk Extreme Fit, the smallest 1TB USB-C flash drive. Get up to 400MB/s speeds, Memory Zone app support, and ...

Apple’s M5 chip is the latest evolution of its silicon, debuting in both the iPad Pro and the 14-inch MacBook Pro. The base ...

Overview: USB-C flash drives in 2025 offer direct plug-in compatibility with Android phones, tablets and laptops, making file ...

Gilead's Phase 3 ARTISTRY-1 trial shows its single-tablet HIV regimen of bictegravir and lenacapavir matches the efficacy and safety of current therapy.

Apple redesigned this iPad to handle the kind of multitasking most of us throw at our devices daily. The A16 chip powers through photo editing, gaming and streaming without hesitation. You get 128GB ...

Transferring files between different devices is now simpler with PairDrop. This free, web-based tool allows seamless file ...

Chances are, you're not making the switch to Windows 11 because you're excited about the new OS. Here are some apps that make ...

Gilead's ARTISTRY-1 success boosts shares as its once-daily bictegravir/lenacapavir combo proves non-inferior to complex ...

According to multiple Korean sources, SK hynix is developing a new type of computer memory aimed at accelerating local ...